Skip to content
Homepage
Author:
ZENTALIS PHARMACEUTICALS
Posted Date:
August 6, 2026
Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates
ZENTALIS PHARMACEUTICALS
August 6, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZENTALIS PHARMACEUTICALS
August 3, 2026
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
ZENTALIS PHARMACEUTICALS
July 17, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZENTALIS PHARMACEUTICALS
June 1, 2026
